INDBInternet News Database 2.5 Updated just now · 297 sources Show or hide images Light or dark

CureGene Presents Two Preclinical Studies of CG-0416 at Obesity Week 2026

Save Like Comments Compare coverage

Summary

CG-0416 combined with a reduced-dose GLP-1 receptor agonist produced greater weight loss, and slower weight regain after the agonist was stopped

Description from Amherst Bee.

Who is covering this

  1. Amherst Bee Not rated US
    CureGene Presents Two Preclinical Studies of CG-0416 at Obesity Week 2026

    CG-0416 combined with a reduced-dose GLP-1 receptor agonist produced greater weight loss, and slower weight regain after the agonist was stopped

Comments

Comments need JavaScript.